Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial In Patients With Advanced Cancer And Leukemia

This study has been terminated.
(The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014 development. There were no safety/efficacy concerns behind the decision.)
Information provided by (Responsible Party):
Pfizer Identifier:
First received: April 6, 2009
Last updated: August 8, 2016
Last verified: August 2016